Skip to main content
Elos Medtech logo

Elos Medtech — Investor Relations & Filings

Ticker · ELOS ISIN · SE0000120776 LEI · 529900I5MSNU451FL670 ST Manufacturing
Open in API
Filings indexed 331 across all filing types
Latest filing 2022-04-12 Annual Report (ESEF)
Country SE Sweden
Listing ST ELOS

About Elos Medtech

http://elosmedtech.com

Elos Medtech is a contract development and manufacturing organization (CDMO) specializing in the medical device sector. The company partners with medical technology firms, providing comprehensive services that span the entire product lifecycle, from research and development to manufacturing and commercialization. Its core focus areas include dental, orthopedics, and advanced surgical products. Elos Medtech offers a range of capabilities, including precision manufacturing, polymer injection molding, process optimization, packaging, and regulatory support. The company operates through specialized business units that collaborate to provide clients with tailored solutions, aiming to streamline operations, reduce complexity, and accelerate innovation in the medical device field.

Recent filings

Filing Released Lang Actions
Annual Report (ESEF) 2021
Annual Report (ESEF) Classification · 100% confidence FY 2021
2022-04-12 Swedish
Kallelse till årsstämma i Elos Medtech AB (publ)
AGM Information Classification · 99% confidence The document is titled "Kallelse till årsstämma i Elos Medtech AB (publ)" which translates to "Notice of Annual General Meeting in Elos Medtech AB (publ)". It details the date, procedures (voting by mail due to temporary exceptions), agenda items (election of board members, auditor, approval of remuneration report, etc.), and proposals to be voted upon at the meeting. This content directly corresponds to the purpose of an Annual General Meeting notice, which is to inform shareholders and solicit their votes/attendance. The closest matching category is AGM Information (AGM-R). Although it contains elements that might be found in a Proxy Statement (PSI), the primary function here is the formal notice and agenda for the AGM itself.
2022-03-31 Swedish
Notice to attend the Annual General Meeting of Elos Medtech AB (publ)
AGM Information Classification · 100% confidence The document is explicitly titled "Notice to attend the Annual General Meeting of Elos Medtech AB (publ)". It details the date, location (virtual attendance), procedures for advance voting (postal voting), the proposed agenda items (including election of Chairman, Board members, auditor remuneration, and profit appropriation), and specific proposals related to these AGM matters. This content perfectly aligns with the definition of materials shared during an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2022-03-31 English
Elos Medtech announces timeline for CEO transition
Board/Management Information Classification · 99% confidence The document explicitly announces a change in senior management: the timeline for the current CEO's departure and the appointment of an interim CEO and deputy CEO. This directly aligns with the definition for Board/Management Information (MANG), which covers 'Announcement of changes in the company's board of directors or senior management.' The document is a formal announcement dated March 16, 2022, detailing executive transitions.
2022-03-16 English
Elos Medtech tillkännager tidpunkten för när VD lämnar sin position
Board/Management Information Classification · 98% confidence The document text is a formal announcement in Swedish regarding the departure of the current CEO (Jan Wahlström) and the appointment of interim replacements (Jodie Gilmore and Søren Olesen) effective from the date of the Annual General Meeting (AGM) on May 3rd. This content directly relates to changes in senior management and the board structure, which aligns perfectly with the definition for 'Board/Management Information' (MANG). The document is short and is an announcement, not a transcript or a full report.
2022-03-16 Swedish
Earnings Release 2021
Earnings Release Classification · 99% confidence The document is titled "BOKSLUTSKOMMUNIKÉ" (Year-End Report/Financial Communication) and provides detailed financial results for Q4 2021 and the full year 2021 (Januari - december 2021). It includes key metrics like Net Sales (Nettoomsättning), Operating Profit (Rörelseresultat), Net Profit (Resultat efter skatt), Cash Flow (Kassaflöde), and Balance Sheet figures. It also contains a CEO commentary and segment reporting. This structure is characteristic of a comprehensive financial report covering a full fiscal year, which aligns with the definition of an Annual Report (10-K), although this specific document appears to be the Swedish equivalent or a preliminary release thereof. Since the document provides the full year's comprehensive financial performance and analysis, it is best classified as an Annual Report (10-K) or, if it is a preliminary release preceding the formal 10-K filing, it strongly resembles the content of an Annual Report. Given the options, and the comprehensive nature covering the full fiscal year, 10-K is the most appropriate fit for a full-year financial disclosure, even if the source language is Swedish and the format might be slightly different from a US SEC 10-K filing. It is clearly more detailed than an Earnings Release (ER) or an Interim Report (IR) as it covers the full 12 months. Q4 2021
2022-02-24 Swedish

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.